Allergan Nasal Spray For Frequent Nighttime Urination Faces Review Hurdles

Advisory committee will weigh in on desmopressin as FDA questions broad indication and says clinical meaningfulness of treatment effects for Serenity Pharmaceuticals/Allergan’s product vs. placebo are unclear.

More from US FDA Performance Tracker

More from Regulatory Trackers